X
Search
X

Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.

X

Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

ESMO: When to Order Next-Gen Cancer Sequencing

New recommendations for using next-generation sequencing in the setting of metastastic cancer have been published by the European Society for Medical Oncology (ESMO).

Experts at the organization used a rigorous methodology to identify advanced cancers with firm evidence supporting the clinical utility of next-generation sequencing (NGS), and other cancers with insufficient data to recommend widespread and routine clinical application of this technology (Ann Oncol 2020 Aug 24. [Epub ahead of print]).

Read the full article here. 

source: Clinical Oncology